A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT07215234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy

Interventions

DRUG: SAR446597
DRUG: Sham Comparator

Sponsor

Sanofi